Published in Alzheimers Dement on January 01, 2011
Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial. JAMA (2015) 3.88
Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med (2013) 2.39
Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years. JAMA Intern Med (2013) 2.38
A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Arch Intern Med (2007) 2.20
Assessment of cognition using surveys and neuropsychological assessment: the Health and Retirement Study and the Aging, Demographics, and Memory Study. J Gerontol B Psychol Sci Soc Sci (2011) 2.04
Validation of a cognitive assessment battery administered over the telephone. J Am Geriatr Soc (2012) 1.26
Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 1. Alzheimers Dement (2011) 1.19
Superior memory and higher cortical volumes in unusually successful cognitive aging. J Int Neuropsychol Soc (2012) 1.13
Sleep duration in midlife and later life in relation to cognition. J Am Geriatr Soc (2014) 0.90
Pervasive Computing Technologies to Continuously Assess Alzheimer's Disease Progression and Intervention Efficacy. Front Aging Neurosci (2015) 0.87
Regularity and predictability of human mobility in personal space. PLoS One (2014) 0.86
Design, methods and demographic findings of the DEMINVALL survey: a population-based study of Dementia in Valladolid, Northwestern Spain. BMC Neurol (2012) 0.77
The 5 Objects Test: a novel, minimal-language, memory screening test. J Neurol (2013) 0.76
Epidemiology of Major Neurodegenerative Diseases in Women: Contribution of the Nurses' Health Study. Am J Public Health (2016) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Random-effects models for longitudinal data. Biometrics (1982) 54.17
The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology (1993) 47.72
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc (2005) 27.90
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol (2010) 19.42
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol (2007) 18.62
Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology (2006) 8.97
Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging (2002) 6.18
The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord (2009) 5.50
Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol (2003) 5.17
Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol (2004) 4.89
Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci (1991) 4.53
Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol (2010) 3.64
Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition. Arch Neurol (2009) 3.60
Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology (1995) 3.37
Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol (1999) 3.20
Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol (1998) 2.92
Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology (2010) 2.92
A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease. Stat Med (2000) 2.90
A validation study of the Dementia Questionnaire. Arch Neurol (1994) 2.89
Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology (1994) 2.84
A review of smart homes- present state and future challenges. Comput Methods Programs Biomed (2008) 2.61
fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 2.49
Variability in reaction time performance of younger and older adults. J Gerontol B Psychol Sci Soc Sci (2002) 2.40
Literacy and memory decline among ethnically diverse elders. J Clin Exp Neuropsychol (2003) 2.27
Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol (1999) 2.02
Within-person across-neuropsychological test variability and incident dementia. JAMA (2008) 1.98
Unobtrusive assessment of activity patterns associated with mild cognitive impairment. Alzheimers Dement (2008) 1.95
The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol (2002) 1.92
Effect of literacy on neuropsychological test performance in nondemented, education-matched elders. J Int Neuropsychol Soc (1999) 1.91
Mild cognitive impairment can be detected by multiple assessments in a single day. Neurology (2002) 1.85
Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies. Neuropsychologia (2007) 1.81
Mild cognitive impairment: directions for future research. Neurology (2003) 1.78
An electronic pillbox for continuous monitoring of medication adherence. Conf Proc IEEE Eng Med Biol Soc (2006) 1.72
Neuropsychological data in nondemented oldest old: the 90+ Study. J Clin Exp Neuropsychol (2007) 1.63
Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects. Neuroimage (2010) 1.45
Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals. Neuropsychology (2004) 1.38
Biomarkers of Alzheimer's disease. Neurobiol Dis (2008) 1.37
Relationship of health and demographic characteristics to Mini-Mental State examination score among community residents. Psychol Med (1988) 1.37
Item bias in cognitive screening measures: comparisons of elderly white, Afro-American, Hispanic and high and low education subgroups. J Clin Epidemiol (1995) 1.33
Medication adherence in healthy elders: small cognitive changes make a big difference. J Aging Health (2009) 1.26
Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old. Neurology (2006) 1.25
Education, cognitive test scores, and black-white differences in dementia risk. J Am Geriatr Soc (2006) 1.25
Semantic interference deficits and the detection of mild Alzheimer's disease and mild cognitive impairment without dementia. J Int Neuropsychol Soc (2004) 1.24
Assessment of cognitive decline in old age with brief tests amenable to telephone administration. Neuroepidemiology (2005) 1.23
Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2. Alzheimers Dement (2011) 1.19
Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 1. Alzheimers Dement (2011) 1.19
The smart house for older persons and persons with physical disabilities: structure, technology arrangements, and perspectives. IEEE Trans Neural Syst Rehabil Eng (2004) 1.17
Unobtrusive monitoring of computer interactions to detect cognitive status in elders. IEEE Trans Inf Technol Biomed (2004) 1.15
Sensitivity to semantic cuing: an index of episodic memory dysfunction in early Alzheimer disease. Alzheimer Dis Assoc Disord (1999) 1.15
Functional magnetic resonance imaging changes in amnestic and nonamnestic mild cognitive impairment during encoding and recognition tasks. J Int Neuropsychol Soc (2009) 1.13
Home-based technologies: a new paradigm for conducting dementia prevention trials. Alzheimers Dement (2007) 1.12
Diagnosis of early dementia by the Double Memory Test: encoding specificity improves diagnostic sensitivity and specificity. Neurology (1997) 1.12
Semantic interference in mild Alzheimer disease: preliminary findings. Am J Geriatr Psychiatry (2003) 1.12
Apolipoprotein E, cardiovascular disease and cognitive function in aging women. Neurobiol Aging (2005) 1.08
MMSE cross-domain variability predicts cognitive decline in centenarians. Gerontology (2003) 1.07
Unobtrusive In-Home Monitoring of Cognitive and Physical Health: Reactions and Perceptions of Older Adults. J Appl Gerontol (2008) 1.06
Reaction times and performance variability in normal aging, mild cognitive impairment, and Alzheimer's disease. J Geriatr Psychiatry Neurol (2008) 1.03
Scales as outcome measures for Alzheimer's disease. Alzheimers Dement (2009) 1.02
Free and cued selective reminding and selective reminding in the elderly. J Clin Exp Neuropsychol (1997) 0.98
Vulnerability to proactive semantic interference and progression to dementia among older adults with mild cognitive impairment. Dement Geriatr Cogn Disord (2007) 0.97
Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions. Alzheimers Res Ther (2010) 0.97
Proactive and retroactive interference in young adults, healthy older adults, and older adults with amnestic mild cognitive impairment. J Int Neuropsychol Soc (2009) 0.95
Increased sensitivity to proactive interference in amnestic mild cognitive impairment is independent of associative and semantic impairment. Brain Cogn (2009) 0.90
Intelligence quotient-adjusted memory impairment is associated with abnormal single photon emission computed tomography perfusion. J Int Neuropsychol Soc (2007) 0.89
Mild cognitive impairment: a neuropsychological perspective. CNS Spectr (2008) 0.87
Release from proactive interference in early Alzheimer's disease. Neuropsychologia (1995) 0.81
A novel approach to assessing memory at the population level: vulnerability to semantic interference. Int Psychogeriatr (2010) 0.79
Cognitive phenotypes, brain morphometry and the detection of cognitive decline in preclinical AD. Behav Neurol (2009) 0.79
IQ-based norms for highly intelligent adults. Clin Neuropsychol (2006) 0.78
The exploration & forensic analysis of computer usage data in the elderly. Conf Proc IEEE Eng Med Biol Soc (2009) 0.78
The utility of a brief memory screen in the diagnosis of mild memory impairment in the elderly: preliminary study. Am J Geriatr Psychiatry (2009) 0.76
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med (2005) 12.04
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord (2006) 8.04
Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology (2008) 6.87
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39
Effects of moderate alcohol consumption on cognitive function in women. N Engl J Med (2005) 4.92
Physical activity, including walking, and cognitive function in older women. JAMA (2004) 4.90
Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet (2006) 4.80
Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry (2006) 4.74
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol (2004) 4.66
Physical activity at midlife in relation to successful survival in women at age 70 years or older. Arch Intern Med (2010) 4.45
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging (2009) 4.36
Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol (2008) 3.99
Exposure to particulate air pollution and cognitive decline in older women. Arch Intern Med (2012) 3.78
Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol (2003) 3.75
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol (2007) 3.55
Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol (2003) 3.47
Prospective study of sudden cardiac death among women in the United States. Circulation (2003) 3.45
Total hip replacement due to osteoarthritis: the importance of age, obesity, and other modifiable risk factors. Am J Med (2003) 3.27
A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med (2006) 3.19
Type 2 diabetes mellitus and risk of developing urinary incontinence. J Am Geriatr Soc (2005) 2.86
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative. Lancet Neurol (2007) 2.72
Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch Neurol (2007) 2.68
The trajectory of gait speed preceding mild cognitive impairment. Arch Neurol (2010) 2.66
Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum (2004) 2.62
Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord (2002) 2.56
Status of computerized cognitive testing in aging: a systematic review. Alzheimers Dement (2008) 2.52
Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord (2007) 2.43
Quantitative template for subtyping primary progressive aphasia. Arch Neurol (2009) 2.42
Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med (2013) 2.39
Unobtrusive and ubiquitous in-home monitoring: a methodology for continuous assessment of gait velocity in elders. IEEE Trans Biomed Eng (2009) 2.30
Dietary fat types and 4-year cognitive change in community-dwelling older women. Ann Neurol (2012) 2.29
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol (2006) 2.06
Education, other socioeconomic indicators, and cognitive function. Am J Epidemiol (2003) 1.97
TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathol (2014) 1.90
Cumulative exposure to lead in relation to cognitive function in older women. Environ Health Perspect (2008) 1.87
Dementia assessment in primary care: results from a study in three managed care systems. J Gerontol A Biol Sci Med Sci (2004) 1.86
The association of self-reported sleep duration, difficulty sleeping, and snoring with cognitive function in older women. Alzheimer Dis Assoc Disord (2006) 1.85
Mediterranean diet and cognitive function in older age. Epidemiology (2013) 1.85
Prion protein codon 129 genotype prevalence is altered in primary progressive aphasia. Ann Neurol (2005) 1.83
Safety and acceptability of the research lumbar puncture. Alzheimer Dis Assoc Disord (2005) 1.82
Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol (2004) 1.81
Ecology of the aging human brain. Arch Neurol (2011) 1.78
Prevalence of dementia in three ethnic groups: the South Florida program on aging and health. Ann Epidemiol (2003) 1.77
Imaging markers for Alzheimer disease: which vs how. Neurology (2013) 1.76
Effects of marital transitions on changes in dietary and other health behaviours in US women. Int J Epidemiol (2004) 1.74
Literacy, cognitive function, and health: results of the LitCog study. J Gen Intern Med (2012) 1.73
Anatomy of language impairments in primary progressive aphasia. J Neurosci (2011) 1.70
Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol (2012) 1.65
Risk factors for fecal incontinence in older women. Am J Gastroenterol (2012) 1.64
Quantitative classification of primary progressive aphasia at early and mild impairment stages. Brain (2012) 1.62
Physical activity and cognition in women with vascular conditions. Arch Intern Med (2011) 1.61
Oral contraceptive use and incident urinary incontinence in premenopausal women. J Urol (2009) 1.59
A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep (2003) 1.58
Effect of exercise on cognitive performance in community-dwelling older adults: review of intervention trials and recommendations for public health practice and research. J Am Geriatr Soc (2011) 1.57
Age at onset of Parkinson disease and apolipoprotein E genotypes. Am J Med Genet (2002) 1.56
TARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy. Acta Neuropathol (2009) 1.56
Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. J Alzheimers Dis (2005) 1.55
Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia. Brain (2014) 1.54
Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease. Arch Intern Med (2004) 1.52
Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol (2008) 1.52
When memory does not fail: familiarity-based recognition in mild cognitive impairment and Alzheimer's disease. Neuropsychology (2006) 1.51
Specific subjective memory complaints in older persons may indicate poor cognitive function. J Am Geriatr Soc (2011) 1.50
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimers Dement (2009) 1.49
Primary progressive aphasia: PPA and the language network. Ann Neurol (2003) 1.49
A web-based normative calculator for the uniform data set (UDS) neuropsychological test battery. Alzheimers Res Ther (2011) 1.48
Altered effective connectivity within the language network in primary progressive aphasia. J Neurosci (2007) 1.44
Body mass index, weight gain, and incident urinary incontinence in middle-aged women. Obstet Gynecol (2007) 1.44
Type 2 diabetes mellitus and cognitive decline in two large cohorts of community-dwelling older adults. J Am Geriatr Soc (2008) 1.44
Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging (2006) 1.43
The epidemiology of urinary incontinence in older women: incidence, progression, and remission. J Am Geriatr Soc (2008) 1.41
Incidence and remission of urinary incontinence in middle-aged women. Am J Obstet Gynecol (2007) 1.39
Neurology of anomia in the semantic variant of primary progressive aphasia. Brain (2009) 1.39
The core and halo of primary progressive aphasia and semantic dementia. Ann Neurol (2003) 1.39
Fruit and vegetable consumption and cognitive decline in aging women. Ann Neurol (2005) 1.38
Urinary incontinence and prevalence of high depressive symptoms in older black versus white women. Int Urogynecol J (2014) 1.38
Plasma amyloid-β as a predictor of dementia and cognitive decline: a systematic review and meta-analysis. Arch Neurol (2012) 1.37
A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr (2008) 1.37
Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years. BMJ (2004) 1.36
Concurrent impairments in sleep and memory in amnestic mild cognitive impairment. J Int Neuropsychol Soc (2012) 1.35
Increased frequency of learning disability in patients with primary progressive aphasia and their first-degree relatives. Arch Neurol (2008) 1.34
Low dose aspirin and cognitive function in the women's health study cognitive cohort. BMJ (2007) 1.34
A novel frontal pathway underlies verbal fluency in primary progressive aphasia. Brain (2013) 1.32
II. NIH Toolbox Cognition Battery (CB): measuring executive function and attention. Monogr Soc Res Child Dev (2013) 1.29
Neuropathologic basis of white matter hyperintensity accumulation with advanced age. Neurology (2013) 1.29
Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia. Brain (2012) 1.26
Words and objects at the tip of the left temporal lobe in primary progressive aphasia. Brain (2013) 1.26
Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord (2010) 1.24
Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann Neurol (2012) 1.23
BMI, waist circumference, and incident urinary incontinence in older women. Obesity (Silver Spring) (2008) 1.23
Adiposity and weight change in mid-life in relation to healthy survival after age 70 in women: prospective cohort study. BMJ (2009) 1.22
Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study. Circulation (2009) 1.22
Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment. J Mol Neurosci (2003) 1.22
Does caregiving stress affect cognitive function in older women? J Nerv Ment Dis (2004) 1.21
Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 1. Alzheimers Dement (2011) 1.19
Behavioral change in persons with dementia: relationships with mental and physical health of caregivers. J Gerontol B Psychol Sci Soc Sci (2002) 1.19